Plasma chitotriosidase and carotid intima–media thickness in children with sickle cell disease

Abstract

The relationship between chronic hemolysis with subsequent iron overload, inflammation, and premature atherosclerosis has been documented in hemolytic anemias, particularly β-thalassemia. However, no such relationship has been established in sickle cell disease (SCD). We sought to evaluate SCD as a risk factor for early vascular insult by measuring carotid intima-media thickness (CIMT) and plasma chitotriosidase and to assess the role of the latter as a potential quantitative indicator of vascular inflammation and atherogenesis. Thirty SCD pediatric patients (3-18years) and 30 matched controls were enrolled. Full clinical history, with hematological and biochemical parameters, was evaluated. CIMT and chitotriosidase activity were also assessed for all study participants. CIMT values were significantly higher in SCD patients (median 0.42; range 0.32-0.6mm) compared to controls (0.36; 0.34-0.45mm), P=0.03. CIMT correlated positively with age (r=0.460, P=0.011), and total number of vascular incidents necessitating hospital admission (r=0.439, P=0.015). Similarly, chitotriosidase activity was significantly higher among SCD patients (median 59.6; range 7.3-512nmol/ml plasma/h) compared to controls (32.7; 6.8-63.1nmol/ml plasma/h), P<0.001, and showed a positive correlation with serum ferritin (r=0.517, P=0.003) and CIMT (r=0.535, P=0.002). SCD children are at risk of developing premature atherogenic changes. Plasma chitotriosidase and CIMT may represent useful predictors of these changes.